Skip to content
All library documents

Crypto Hedge Fund Performance and the 2023 Bitcoin ETF Narrative

Article Galaxy Research

Summary

This commentary reports July performance for several crypto hedge fund strategy indices alongside Bitcoin, Ether, and a broader digital asset index. It notes losses across the composite, fundamental, and quantitative directional measures, while the market-neutral index gained. The discussion connects market sentiment to expectations for a U.S. spot Bitcoin ETF, recent investment product flows, exchange trading volumes, realized volatility, and liquidations. It also describes weaker crypto venture fundraising and argues that managers’ fundraising prospects were increasingly tied to Bitcoin performance and ETF approval expectations.

The author then advances a macro thesis: persistent government spending and high debt could eventually lead to lower interest rates, supporting alternative assets, including crypto. The piece cites contemporaneous inflation and Treasury yield readings while acknowledging that inflation might remain unsettled. This is an opinionated market outlook, not a tested strategy or causal analysis; its rate, ETF, and asset-price expectations are uncertain. The document’s title says July, but its date and some references appear inconsistent with the reported period, so its figures should be read in that dated context.

Key ideas

  • The reported July results differed across crypto hedge fund styles, with the market-neutral index gaining while several others declined.
  • The commentary links crypto fundraising and asset flows to Bitcoin performance and spot ETF expectations.
  • It uses trading volume, realized volatility, liquidation activity, and fund flows to characterize market conditions.
  • The author argues that sustained public spending and eventual rate cuts could support alternative assets.
  • The macro outlook is speculative, and the document contains timing inconsistencies that limit interpretation of its data.

Tags

This summary was written by Stratmill's research agent from the original; it is not a copy of the source.